(openPR) - The industrial gas specialist Messer receives European safety awards.
The Messer Group was presented with three awards for accident-free work at this year’s European Industrial Gases Association (EIGA) conference in Düsseldorf. A Czech and a Bosnian subsidiary of the industrial gas specialist each received a silver EIGA award for ten years of accident-free work. Both are gas cylinder filling plants. The Latvian Messer subsidiary Elme Messer in Riga also received a silver award for 500,000 accident-free work hours.
Stefan Messer, owner and CEO, was appointed EIGA President on 1 November 2007. The European Industrial Gases Association is based in Brussels. From this location, it represents the vast majority of European companies that produce and distribute industrial, medical and food gases. The member companies closely co-operate in trying to achieve the highest possible standards in terms of safety and environmental protection during the production, transportation and application of gases.
Messer Group GmbH
Vice President
Corporate Communications
Diana Buss
Gahlingspfad 31
47803 Krefeld
Messer is a leading industrial gas enterprise with more than 60 companies operating in over 30 countries in Europe and Asia as well as in Peru, including non-consolidated companies. The international activities are headed from Frankfurt/Main, while the central technical functions of Logistics, Engineering and Production as well as Applied Technology are controlled from Krefeld. The Messer Group had more than 4,400 employees in 2007. From acetylene to xenon, the Messer Group has one of the most diverse product portfolios on the market – it produces industrial gases such as oxygen, nitrogen, argon, carbon dioxide, hydrogen, helium, shielding gases for welding, specialty gases, medical gases and many different gas mixtures.
The Messer Group has state-of-the-art research and competence centers in which it develops applied technologies for the use of gases in almost every sector of industry, in food technology and environmental technology, medicine as well as research and science.
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.